Previous close | 0.6800 |
Open | 0.8000 |
Bid | 0.9000 |
Ask | 1.0500 |
Strike | 7.50 |
Expiry date | 2024-12-20 |
Day's range | 0.8000 - 1.0500 |
Contract range | N/A |
Volume | |
Open interest | 155 |
On May 14, 2024, Director Jane Kiernan purchased 19,356 shares of Treace Medical Concepts Inc (NASDAQ:TMCI), as reported in the SEC Filing.
On May 10, 2024, Deepti Jain, Director at Treace Medical Concepts Inc (NASDAQ:TMCI), purchased 25,000 shares of the company, as reported in a recent SEC Filing.
On May 13, 2024, Richard Mott, a Director at Treace Medical Concepts Inc (NASDAQ:TMCI), purchased 120,000 shares of the company, as reported in a recent SEC Filing.